Risk Factors Associated With an Impaired Antibody Response in Kidney Transplant Recipients Following 2 Doses of the SARS-CoV-2 mRNA Vaccine

Background. Data about vaccine efficacy in solid organ transplant patients are limited. We previously reported our initial observation of a 6.2% immunogenicity rate in kidney transplant recipients (KTRs) after administration of 1 dose of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-...

Full description

Bibliographic Details

Published in:	Transplantation Direct
Main Authors:	Stephanie G. Yi, MD, MPH, Linda W. Moore, PhD, Todd Eagar, PhD, Edward A. Graviss, PhD, MPH, FIDSA, Duc T. Nguyen, MD, PhD, Hassan Ibrahim, MD, MS, Howard J. Huang, MD, Mark Hobeika, MD, Robert McMillan, MD, MPH, Ashish Saharia, MD, Constance Mobley, MD, PhD, Hemangshu Podder, MD, PhD, Ashley Drews, MD, R. Mark Ghobrial, MD, PhD, A. Osama Gaber, MD, Richard J. Knight, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2022-01-01
Online Access:	http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001257